-
Influential medical group advises against Gilead's remdesivir in COVID critical
Gilead’s remdesivir, now known as Veklury, is perhaps the most successful COVID-19 drug so far. It scored a full FDA nod in October after months of e...
2020-11-16 16:10 -
Novavax COVID-19 vaccine granted Fast Track Designation by U.S. FDA
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. F...
2020-11-16 15:23 -
Fluvoxamine may prevent serious illness in COVID-19 patients
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes
2020-11-16 15:16 -
European Commission approves contract with BioNTech-Pfizer alliance
European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 milli...
2020-11-16 15:15 -
Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID
Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK have announced the start of Phase 2/3 clinical trials of its plant-derived...
2020-11-16 15:13 -
Swissmedic begins rolling review of Moderna's mRNA vaccine against COVID-19
Biotechnology company Moderna, Inc. a pioneer in messenger RNA (mRNA) therapeutics and vaccines that create the next generation of transformative medi...
2020-11-16 15:10 -
Research status of new drug delivery system for apatinib
Apatinib (Apa) is a small molecule targeted tumor therapy drug. Its main anti-tumor mechanism is to highly selectively bind and inhibit vascular endot...
2020-11-16 10:39 -
Vitamin H: Slow increase in terminal demand and overcapacity
Vitamin H is one of the B vitamins, also known as biotin, vitamin B7, coenzyme R (Coenzyme R), etc. It is an essential substance for the synthesis of ...
2020-11-13 10:12 -
Diabetes Drugs Market Competitive Landscape
The diabetes drugs market is fragmented with hardly any significant and generic players. The market for insulin drugs and Sglt-2 drugs is dominated by...
2020-11-11 17:53 -
Diabetes Drugs Market Status 2018-2022
The global diabetes market has been growing steadily in recent years, with the global diabetes drug market reaching USD 83 billion in 2018 and is expe...
2020-11-11 17:44
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products
Related Producers
